Glaukos outlines 2026 sales target of $600M–$620M as iDose TR and Epioxa drive growth momentum [Seeking Alpha]
Glaukos Corporation (GKOS)
Last glaukos corporation earnings: 2/27 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.glaukos.com/investors/investor-overview/default.aspx
Company Research
Source: Seeking Alpha
Glaukos Chairman & CEO Thomas Burns reported record fourth quarter consolidated net sales of $143.1 million, reflecting an increase of 36% year-over-year, and full-year 2025 net sales of $507.4 million, up 32% from 2024. Burns stated, "We are also reaffirming our Quick Insights Growth is primarily driven by continued iDose TR adoption in U.S. glaucoma and the ramp-up of newly launched Epioxa in corneal health. Management expects volatility in corneal health revenues due to transition from Photrexa to Epioxa, mainly from adoption hurdles and payer headwinds for Epioxa. Glaukos will continue investing heavily in awareness and access but aims to balance capital investments with revenues to drive toward cash flow breakeven or generation in 2026. Recommended For You More Trending News
Show less
Read more
Impact Snapshot
Event Time:
GKOS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GKOS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GKOS alerts
High impacting Glaukos Corporation news events
Weekly update
A roundup of the hottest topics
GKOS
News
- Glaukos (NYSE:GKOS) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $131.00 price target on the stock.MarketBeat
- Glaukos (NYSE:GKOS) had its "buy" rating reaffirmed by analysts at Needham & Company LLC.MarketBeat
- Glaukos (NYSE:GKOS) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.MarketBeat
- Glaukos Corp (GKOS) Q4 2025 Earnings Call Highlights: Record Sales and Strong Growth Outlook [Yahoo! Finance]Yahoo! Finance
- Glaukos Corporation (GKOS) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
GKOS
Earnings
- 2/17/26 - Miss
GKOS
Sec Filings
- 2/17/26 - Form 8-K
- 2/17/26 - Form SCHEDULE
- 2/11/26 - Form SCHEDULE
- GKOS's page on the SEC website